IFNG and neoplasm: Interestingly, when GVAX was recently combined with PEGPH20, a stromal hyaluron (HA)-degrading agent, in a metastatic, murine PDAC model, an increase in effector memory T cells (which were CCR7−), along with increased tumor-specific IFN-γ, was observed [194].